Filter
663
Text search:
leprosy
treatment
Featured
93
279
Language
Document type
485
55
55
29
21
8
5
3
2
Countries / Regions
67
41
34
30
27
26
23
21
19
19
19
14
14
14
13
12
10
7
6
6
5
5
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
390
70
35
11
10
9
8
3
Toolboxes
113
86
36
22
15
14
8
8
6
5
4
4
4
3
2
2
2
1
1
1
1
1
ILEP Technical Guide
The Leprosy Programme and Transmission Assessment (LPTA) is an activity that is carried out by internal teams towards the end of Phase 1 (see Leprosy Elimination Framework in the Annex) when a subna
...
Towards Universal Access to Prevention, Diagnosis and Treatment
India: NLEP-guidelines on reduction of stigma and discrimination against persons affected by leprosy
National Guidelines India
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im
...
Meeting the rehabilitation needs of people affected by leprosy and promoting quality of life.
Bull World Health Organ 2022;100:50–59 | doi: http://dx.doi.org/10.2471/BLT.21.286689
Course contents: What is Leprosy? Leprosy is a disease caused by a micro-organism called Mycobacterium leprae
Onchocerciasis used to be an important public health problem in Africa, with over 37 million people infected and millions suffering from debilitating skin disease, terrible itching, impaired vision and
blindness. But the epidemiological situation has improved dramatically over the last two decades.
...
Good practice examples from India
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectio
...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, t
...
